CHANESSE SWANSON: Open Payments
NPI 1245780717 · CANTON, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 18 payments from 11 companies in 2025. Trend: 2023 $56 · 2024 $95 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $73 |
| Amgen Inc. | 3 | $47 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Novo Nordisk Inc | 2 | $32 |
| Janssen Biotech, Inc. | 1 | $32 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| UCB, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Dexcom, Inc. | 1 | $17 |
Products named: SKYRIZI, Ozempic, TREMFYA, OTEZLA, ILUMYA, DUPIXENT, EVENITY, Bimzelx.
Industry payments across SD — which companies pay providers there.
